Inventor · disambiguated record
Charles G. Clark
Also filed as: CLARK CHARLES G
24 granted patents·1 pending application·573 citations·filing 1982–2017
96Inventor score
Files withBRISTOL MYERS SQUIBB CO10BRISTOL MYERS SQUIBB PHARMA CO9CLARK CHARLES G1DU PONT PHARM CO1LAM PATRICK Y S1
Top patents by PatentIndex Score
25 records- 0197US6339099B1Guanidine mimics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted Jan 15, 2002·128 cites·40 claims
- 0295US6541639B2Efficient ligand-mediated Ullmann coupling of anilines and azolesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 1, 2003·92 cites·29 claims
- 0394US6500855B1Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Dec 31, 2002·40 cites·16 claims
- 0491US6673810B2Imidazo-heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 6, 2004·43 cites·21 claims
- 0590US6602871B2Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 5, 2003·20 cites·24 claims
- 0690US6369227B1Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Apr 9, 2002·44 cites·13 claims
- 0790US4540171AVariable resistance exercise apparatusCLARK CHARLES G·Filed 1982·Granted Sep 10, 1985·105 cites·12 claims
- 0887US7235575B2Guanidine mimics as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 26, 2007·4 cites·21 claims
- 0987US6906070B2Guanidine mimics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 14, 2005·13 cites·18 claims
- 1083US7388021B2Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·8 cites·18 claims
- 1179US6413980B1Nitrogen containing heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Jul 2, 2002·41 cites·78 claims
- 1277US7674828B2Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 9, 2010·3 cites·8 claims
- 1377US6403583B1Thrombin or factor Xa inhibitorsFiled 1999·Granted Jun 11, 2002·17 cites·27 claims
- 1474US6958356B2Guanidine mimics factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Oct 25, 2005·4 cites·54 claims
- 1573US7381732B2Pyrazolobenzamides and derivatives as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 3, 2008·1 cites·5 claims
- 1671US6858616B2Nitrogen containing heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 22, 2005·4 cites·21 claims
- 1764US8901115B2Cyclic P1 linkers as factor XIa inhibitorsLAM PATRICK Y S·Filed 2012·Granted Dec 2, 2014·1 cites·12 claims
- 1856US9108981B2Cyclic P1 linkers as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·0 cites·11 claims
- 1953US7960569B2Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 14, 2011·0 cites·4 claims
- 2053US6839992B1Quilting frame apparatusFiled 2004·Granted Jan 11, 2005·5 cites·16 claims
- 2148US2004038980A1Imidazo-heterobicycles as factor xa inhibitorsFiled 2003·Application pending·0 cites
- 2247US9315519B2Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·0 cites·18 claims
- 2345US9428504B27-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptorBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·2 claims
- 2445US9403774B2Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 2, 2016·0 cites·17 claims
- 2538US11008317B2Triazolopyridine inhibitors of myeloperoxidase and/or EPXBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 18, 2021·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Charles G. Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →